Agenda Day 2

Embark on an exhilarating adventure at this year's LogiPharma as you navigate a captivating scavenger hunt designed to ignite your curiosity and foster connections! Uncover hidden treasures within the conference venue, solve brain-teasing puzzles, and collaborate with fellow participants to unlock the secrets scattered throughout the event space.

• To balance sustainability goals and cost considerations, how can you leverage innovation and technology within the pharmaceutical supply chain?

• What life cycle assessment methodologies can be employed to evaluate the entire life cycle of products and how can you use these assessments to inform decision-making regarding sustainable practices and their associated costs?

• How do you engage with pharmaceutical suppliers to ensure adherence to sustainable practices?

• What specific metrics and key performance indicators (KPIs) can you use to measure and monitor the environmental performance of your supply chain and how can you ensure a balanced approach with cost considerations factored in?

• What initiatives can you implement to promote sustainable sourcing practices for raw materials and components

within your supply chain?

• How can your incorporate green manufacturing processes to minimize the environmental footprint in the production phase of your supply chain?

• Considering the environmental impact of packaging, what initiatives can you undertake to implement sustainable packaging solutions to play your part in reducing waste and promoting eco-friendly packaging practices?

• What steps can you take to enhance efficiency and reduce environmental impact? – e.g. through optimize transportation, reduce emissions, and improve overall logistics sustainability within your distribution network

• How to collaborate with suppliers, manufacturers, and distributors to implement and coordinate sustainability initiatives across the entire supply chain

• How to leverage collaborative technologies or platforms to facilitate communication and coordination among

suppliers, distributors, and other key partners in your global supply chain network

• What strategies can you employ for effective relationship management and to ensure open communication, mutual understanding, and alignment of goals across the supply chain network?

• Given the complexity of global supply chains, how can you better encourage and facilitate cross-functional collaboration between different departments and stakeholders?

Reserved for Dokasch

• What criteria to use to effectively select contract manufacturers for different aspects of the supply chain? – Key considerations that influence the decision-making process could include manufacturing capabilities, quality standards, and regulatory compliance – what’s more?

• What are the specific metrics and key performance indicators (KPIs) used to assess the effectiveness and reliability of different contract manufacturing partnerships?

• In a highly regulated industry like pharmaceuticals, how can you better implement risk mitigation strategies to ensure compliance, quality assurance, and contingency planning in contract manufacturing relationships?

• How can you foster effective communication and collaboration with contract manufacturers for different aspects of the supply chain?

• How can you ensure flexibility and adaptability in contract manufacturing relationships to accommodate changes in market demands, regulations, or other factors affecting the supply chain?

• How can you stay informed about the diverse and evolving regulatory frameworks globally? Are there strategies and

tools you can employ to gather regulatory intelligence and monitor changes in regulations that impact the supply chain?

• Given the diversity of regulations, how can you develop and implement adaptive compliance strategies within the supply chain and balance the need for compliance with the imperative of maintaining operational efficiency?

• How do you collaborate with regulatory bodies and authorities in different regions to ensure alignment with local regulations?

• Is there room for proactive engagement with regulatory bodies to contribute to streamlined compliance processes?

• How can technology integration support compliance efforts while enhancing operational efficiency?

• Given the complexity of global regulatory frameworks, how do you prioritize continuous learning and awareness programs to contribute to building a culture of compliance within the organization?

• What strategies can you employ to address unique pharmaceutical supply chain challenges associated with market entry – e.g. how are distribution networks, regulatory compliance, and local partnerships adapted to navigate challenges in

emerging markets?

• How to navigate through regulatory differences in these markets while ensuring product quality, safety, and timely market access

• Given the varying levels of infrastructure in emerging markets, how can you best address challenges related to transportation, warehousing, and logistics?

• How to assess and manage risks within the supply chain that is associated with expanding into emerging markets

• How to approach partnerships and collaborations with local entities in emerging markets

Reserved for commercial partner

• How can you conduct assessments to understand the specific healthcare needs of patients in emerging markets?

• How to account for cultural and linguistic factors that may impact patient understanding and adherence and improve communication and accessibility for patients in diverse cultural settings

• Considering economic diversity in emerging markets, would pricing models, distribution networks, or partnerships need to be adapted to ensure wider access to medications in these regions?

• How can you tailor your distribution strategies to navigate issues such as transportation, storage, and last-mile delivery in regions with diverse infrastructure capabilities?

• To move towards greater patient-centricity, do you implement healthcare education initiatives to promote awareness and understanding of pharmaceutical products in emerging markets?

• Based on recent challenges and disruptions to the supply chain, how have key lessons influenced your approach to supply chain management, resilience, and innovation?

• What adaptive mechanisms and processes can you implement in response to evolving industry dynamics? Are they any specific mechanisms or frameworks that can help to enhance agility, responsiveness, and risk mitigation within the supply chain?

• Given the pace of innovation in the pharmaceutical industry, how do you integrate innovation strategies into the supply chain to address market demands and industry shifts?

• With the lessons learnt, how would they influence your initiatives or partnerships among different stakeholders – e.g. any changes to enhance communication, visibility, and joint problem-solving?

• Are there any instances where a commitment to learning from challenges has led to strategic improvements, better performance, or enhanced market responsiveness?